Saturday, December 15, 2012

Primatene Mist to make a comeback? | Redux

Posted by

Primatene Mist to make a comeback?

Allergy Relief for Your Child
Allergy Relief for Your Child by The U.S. Food and Drug Administration
License (according to Flickr): United States Government Work
Excerpt:

(CBS News) For millions of asthma sufferers, a medical inhaler is one of the most effective ways to control symptoms. For almost half a century, America's most popular choice was Primatene Mist. Congress is now ready to decide if it should be sold again. Primatene Mist was appealing to many asthma sufferers because it didn't require a prescription. But Wednesday's move to allow the inhaler to return to store shelves has also been met with opposition from the medical community, which says Primatene Mist isn't the best way to treat asthma. Later Wednesday, members of the House of Representatives are expected to vote on whether to give Primatene Mist back to consumers. At the start of 2012, the popular over-the-counter inhaler was pulled from drugstore shelves for containing chlorofluorocarbons, or CFCs, which are considered one of the primary causes for the depletion of the ozone layer.

Keywords:

Primatene Mist asthma asthma sufferers inhaler medical community Primatene Mist inhalers popular over-the-counter inhaler environmentally friendly version U.S. Rep. Michael CFCs Dr. Daniel Ein medical inhaler adverse cardiopulmonary effects significant health risk best possible care company asthma patients asthma attack drugstore shelves effective ways CBS News inhaled epinephrine over-the-counter option best way primary causes United States Drug Administration ozone layer low-income homes Amphastar Pharmaceuticals excess stock possible return expiration date Sinus Center American College Georgetown University Chip Reid encourage people to get the California warehouse opposition symptoms charity Wednesday manufacturer Allergy consumers time chlorofluorocarbons marketshare depletion

People:

Chip Reid

Overall Sentiment: 0

Relevance: 0.239833

Dr. Daniel Ein

Overall Sentiment: -0.0255357

Relevance: 0.210034

Rep. Michael Burgess

Overall Sentiment: 0

Relevance: 0.200027

SentimentQuote
-0.100379Rep. Michael Burgess, R-Texas, said, "The tiny amount of CFCs that are disbursed in treatment of an asthma attack is absolutely minuscule, and it really makes no sense to prevent asthma patients from having that therapy available."
Sentiment Stats:
  • Number of Quotes: 1
  • Aggregate Sentiment: -0.100379
  • Mean: -0.100379
  • Standard Deviation: 1.4142135623731

Key:

  • Aggregate Sentiment is meant to be an indicator of an individual's overall sentiment.
  • The Mean is meant to be an indicator of an individual's average comment sentiment.
  • The Standard Deviation, when there are enough quotes, will indicate an individual's consistency of sentiment (i.e. a Standard Deviation of 0 would mean they were very consistent in their sentiment and 1 would mean they were very inconsistent).

Note that quote stats are likely to be meaningless beyond the aggregate score due to the tiny sample size. However, they are always provided just in case you find something useful there.

Additional Info:

HealthCondition: asthma

Overall Sentiment: -0.216525

Relevance: 0.823017

Disambiguation: DiseaseOrMedicalCondition | CauseOfDeath | DiseaseCause | RiskFactor | Symptom | DiseaseReferences:
Webpage Meta Tags Info
at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)